ArticleJAMA internal medicine2021

Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.

Matthew S Krantz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.